About Takeda Pharmaceuticals
Takeda Pharmaceuticals is a Healthcare company based in London (United Kingdom) founded in 2016, and was acquired by Takeda in October 2021. Immunotherapeutics for cancer are developed using gamma delta T cells. It operates on a Direct-to-Consumer (D2C) and Professional Services model. Takeda Pharmaceuticals offers products and services including Oveporexton (TAK-861), Plasma-Derived Therapies, and Vaccines. Its focus areas include Pharmaceuticals, Biopharmaceuticals, Biotechnology and Rare Disease Treatments. Its legal entity is Takeda Pharmaceutical Company Limited.
Company details
Takeda Pharmaceuticals is focused on the research and development of transformative medicines. Operations are conducted in multiple therapeutic areas including gastrointestinal, inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines. Solutions are provided to address unmet medical needs worldwide, with a commitment to improving health outcomes. The company operates in numerous countries, ensuring access to innovative treatments across diverse markets.
- Headquarters London, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website gammadeltatx.com
- Social LinkedIn YouTube
- Acquired by Takeda (Oct 2021)
- Legal Name Takeda Pharmaceutical Company Limited
- Investors
- Acquired byTakeda
(Oct 2021)
Products & Services of Takeda Pharmaceuticals
Takeda Pharmaceuticals offers a comprehensive portfolio of products and services, including Oveporexton (TAK-861), Plasma-Derived Therapies, and Vaccines.
Developed for treating Narcolepsy Type 1 patients.
Innovated for rare and complex chronic diseases.
Created to address global infectious disease needs.
Apps and channels of Takeda Pharmaceuticals
its YouTube channel Takeda has 23.6K subscribers and 30 videos.
Videos from Takeda Pharmaceuticals
The most watched videos on Takeda Pharmaceuticals's YouTube channel, Takeda (23.6K subscribers). Click a video to play it here.
More on Takeda.
Investors in Takeda Pharmaceuticals
Takeda Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Takeda Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Takeda Pharmaceuticals is engaged in developing innovative medicines globally. | 1781 | takeda.com | Tokyo, Japan |
Investor details for Takeda Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Takeda Pharmaceuticals
3 people are tracked at Takeda Pharmaceuticals (2 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Paolo Paoletti, MD | CEO | Leadership |
Emma Roffe | Director | Leadership |
David Wotherspoon | Scientist | Team |
Complete people profiles for Takeda Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Takeda Pharmaceuticals
2 dated milestones of Takeda Pharmaceuticals across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Takeda Pharmaceuticals is founded.
- Exit Acquired by Takeda.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Takeda Pharmaceuticals
Complete news archive for Takeda Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Takeda Pharmaceuticals
Takeda Pharmaceuticals was founded in 2016.
Takeda Pharmaceuticals is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Takeda Pharmaceuticals is focused on the research and development of transformative medicines. Operations are conducted in multiple therapeutic areas including gastrointestinal, inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines. Solutions are provided to address unmet medical needs worldwide, with a commitment to improving health outcomes. The company operates in numerous countries, ensuring access to innovative treatments across diverse markets.
Takeda Pharmaceuticals offers Oveporexton (TAK-861), Plasma-Derived Therapies, and Vaccines.
Takeda Pharmaceuticals has 1 investor. Key investors include Takeda Pharmaceuticals.
Takeda Pharmaceuticals operates through Takeda Pharmaceutical Company Limited.
Yes. Takeda Pharmaceuticals was acquired by Takeda in October 2021.